Betamethasone with clotrimazole
Brand names: Lotriderm
A topical fixed-combination cream pairing the potent corticosteroid betamethasone with the imidazole antifungal clotrimazole, used for inflamed fungal skin infections such as tinea or candidal intertrigo where inflammation is prominent.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Betamethasone suppresses local inflammation, vasodilatation and immune activity, while clotrimazole inhibits fungal ergosterol synthesis to disrupt the cell membrane of dermatophytes and yeasts.
Prescribing in practice
- The corticosteroid component can mask and worsen an untreated infection, so use should be short-term and limited to genuinely inflamed fungal disease rather than as a routine antifungal.
- Avoid prolonged application to the face, flexures or large areas, and avoid occlusion, which increases corticosteroid potency and absorption.
- Not appropriate as monotherapy for established dermatophyte infection if inflammation is minimal — a plain antifungal is preferred.
Monitoring
Review the response after a short course and reassess the diagnosis if the rash fails to clear or recurs, considering skin scrapings for mycology.
Counselling the patient
- Apply a thin layer to the affected area as directed and do not cover with airtight dressings unless told to.
- Stop and seek advice if the area becomes more sore, weepy or fails to improve.
Evidence & guidelines
Use is guided by SPC recommendations and standard dermatology practice for inflamed superficial fungal infection; consult current prescribing references.
Reference: NICE CKS Tinea; BAD; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD